Blood cancer biobank aims to unlock personalized treatment clues
NCT ID NCT07445438
First seen Mar 23, 2026 · Last updated Apr 30, 2026 · Updated 2 times
Summary
This study collects bone marrow, blood, and tissue samples from over 1,000 people with various blood cancers, including leukemia and myeloma. Researchers will use advanced lab techniques to identify biomarkers and test how cancer cells respond to different drugs. The goal is to better understand these diseases and pave the way for more personalized treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Parma
RECRUITINGParma, PR, 43126, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.